KO
47
-5
GRMN
52
2
SLG
64
-2
AVY
62
8
STX
59
6
BIIB
30
5
HRL
35
-3
HD
54
4
SWN
73
3
AFL
56
-3
CHRW
50
2
RHI
57
5
ADSK
67
2
GS
69
4
CMA
64
5
OI
50
7
HP
45
4
WFC
61
3
XRAY
34
2
MKC
59
-3
KO
47
-5
GRMN
52
2
SLG
64
-2
AVY
62
8
STX
59
6
BIIB
30
5
HRL
35
-3
HD
54
4
SWN
73
3
AFL
56
-3
CHRW
50
2
RHI
57
5
ADSK
67
2
GS
69
4
CMA
64
5
OI
50
7
HP
45
4
WFC
61
3
XRAY
34
2
MKC
59
-3
Financhill
Back

Apellis Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
25

APLS
Apellis Pharmaceuticals

Last Price:
36.70
Seasonality Move:
15.53%
Sell
25

NBY
NovaBay Pharmaceuticals

Last Price:
0.50
Seasonality Move:
-14.79%
Sell
25
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $36.73. The Score for APLS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.50. The Score for NBY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $36.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 45.36 Sell
Chaikin Money Flow: -475428 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.98 - 39.8) Sell
Bollinger Bands (100): (36.68 - 42.54) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 37.14 Sell
Chaikin Money Flow: -28552 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.47 - 0.53) Sell
Bollinger Bands (100): (0.58 - 3.38) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.02 Sell
20-day SMA: 38.38 Sell
50-day SMA: 38.01 Sell
200-day SMA: 50.16 Sell
8-day EMA: 36.95 Sell
20-day EMA: 37.71 Sell
50-day EMA: 38.48 Sell
200-day EMA: 45.83 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.49 Buy
20-day SMA: 0.49 Buy
50-day SMA: 0.86 Sell
200-day SMA: 3.79 Sell
8-day EMA: 0.49 Buy
20-day EMA: 0.53 Sell
50-day EMA: 0.95 Sell
200-day EMA: 8.34 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.24 per share, an increase this year of $3.17 per share, and an increase next year of $1.50 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):